VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K902. A total of 7 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $464,000 | -38.3% | 26,800 | -60.7% | 0.02% | +260.0% |
| Q1 2017 | $752,000 | -70.1% | 68,200 | -60.7% | 0.01% | -58.3% |
| Q4 2016 | $2,518,000 | -16.1% | 173,400 | +41.9% | 0.01% | -14.3% |
| Q3 2016 | $3,000,000 | +495.2% | 122,200 | +388.8% | 0.01% | +600.0% |
| Q2 2016 | $504,000 | -50.5% | 25,000 | -35.4% | 0.00% | -60.0% |
| Q1 2016 | $1,018,000 | -89.2% | 38,700 | -58.3% | 0.01% | -89.1% |
| Q4 2015 | $9,423,000 | -43.0% | 92,700 | +0.1% | 0.05% | -33.3% |
| Q3 2015 | $16,518,000 | +76.2% | 92,600 | +119.4% | 0.07% | +64.3% |
| Q2 2015 | $9,375,000 | -23.3% | 42,200 | -31.4% | 0.04% | -23.6% |
| Q1 2015 | $12,215,000 | +40.2% | 61,500 | +1.0% | 0.06% | +57.1% |
| Q4 2014 | $8,715,000 | -44.2% | 60,900 | -48.9% | 0.04% | -46.2% |
| Q3 2014 | $15,626,000 | -31.3% | 119,100 | -33.9% | 0.06% | -36.9% |
| Q2 2014 | $22,739,000 | +109.1% | 180,300 | +118.5% | 0.10% | +123.9% |
| Q1 2014 | $10,876,000 | +29.8% | 82,500 | +15.5% | 0.05% | +53.3% |
| Q4 2013 | $8,382,000 | +16.6% | 71,400 | +3.6% | 0.03% | +20.0% |
| Q3 2013 | $7,188,000 | -9.9% | 68,900 | -25.7% | 0.02% | -13.8% |
| Q2 2013 | $7,980,000 | – | 92,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|